Skip to main content

ADVERTISEMENT

Jolynn Tumolo

News
04/14/2023
Jolynn Tumolo
Declining mental health in children is a long-term consequence of decades of shrinking opportunities for children and teens to participate in independent activities away from the direct oversight of adults, some experts say.
Declining mental health in children is a long-term consequence of decades of shrinking opportunities for children and teens to participate in independent activities away from the direct oversight of adults, some experts say.
Declining mental health in...
04/14/2023
Psych Congress Network
News
04/14/2023
Jolynn Tumolo
Treatment with biosimilar adalimumab was associated with a significant improvement in ankylosing spondylitis symptoms for up to 1 year, according to new findings.
Treatment with biosimilar adalimumab was associated with a significant improvement in ankylosing spondylitis symptoms for up to 1 year, according to new findings.
Treatment with biosimilar...
04/14/2023
First Report Managed Care
News
04/14/2023
Jolynn Tumolo
Class II recalls have been issued for multiple statins manufactured by two firms and distributed throughout the United States.
Class II recalls have been issued for multiple statins manufactured by two firms and distributed throughout the United States.
Class II recalls have been...
04/14/2023
Pharmacy Learning Network
News
04/14/2023
Jolynn Tumolo
Teva Pharmaceuticals is voluntarily recalling a prescription drug used to control asthma and relieve symptoms of allergic rhinitis.
Teva Pharmaceuticals is voluntarily recalling a prescription drug used to control asthma and relieve symptoms of allergic rhinitis.
Teva Pharmaceuticals is...
04/14/2023
Pharmacy Learning Network
News
04/14/2023
Jolynn Tumolo
A prescription medication used to treat anxiety and panic disorder is under a Class II recall due to cross contamination concerns.
A prescription medication used to treat anxiety and panic disorder is under a Class II recall due to cross contamination concerns.
A prescription medication used...
04/14/2023
Pharmacy Learning Network
News
04/11/2023
Jolynn Tumolo
All-cause mortality rates in US patients with Parkinson disease psychosis were lower among those treated with pimavanserin compared with other atypical antipsychotics over 12 months, according to a retrospective study published in Drug...
All-cause mortality rates in US patients with Parkinson disease psychosis were lower among those treated with pimavanserin compared with other atypical antipsychotics over 12 months, according to a retrospective study published in Drug...
All-cause mortality rates in US...
04/11/2023
Neurology
News
04/06/2023
Jolynn Tumolo
Patient subgroup restrictions varied widely across health plans, which could create access challenges for patients within approved populations for orphan and FDA-expedited drugs, researchers said.
Patient subgroup restrictions varied widely across health plans, which could create access challenges for patients within approved populations for orphan and FDA-expedited drugs, researchers said.
Patient subgroup restrictions...
04/06/2023
First Report Managed Care
News
04/06/2023
Jolynn Tumolo
The addition of a digital therapeutic to lifestyle modification guidance improved home blood pressure in patients with unmedicated hypertension more than lifestyle modification alone, according to new findings.
The addition of a digital therapeutic to lifestyle modification guidance improved home blood pressure in patients with unmedicated hypertension more than lifestyle modification alone, according to new findings.
The addition of a digital...
04/06/2023
First Report Managed Care
News
04/05/2023
Jolynn Tumolo
Several strengths of glimepiride tablets have been issued a Class II recall for deviations from Current Good Manufacturing Practices.
Several strengths of glimepiride tablets have been issued a Class II recall for deviations from Current Good Manufacturing Practices.
Several strengths of glimepiride...
04/05/2023
Pharmacy Learning Network
News
04/05/2023
Jolynn Tumolo
A Class II recall has been issued for over 370,000 bottles of calcitonin salmon nasal spray due to being out of specification for impurities.
A Class II recall has been issued for over 370,000 bottles of calcitonin salmon nasal spray due to being out of specification for impurities.
A Class II recall has been...
04/05/2023
Pharmacy Learning Network